Literature DB >> 15318578

Trends in medical spending by age, 1963-2000.

Ellen Meara1, Chapin White, David M Cutler.   

Abstract

We combine household surveys and total spending data to analyze trends in medical spending from 1963 to 2000. During this nearly forty-year period, spending grew fastest among the elderly. Per person spending among the elderly grew rapidly from 1963 to 1987, but this trend then reversed during the next decade, reflecting reforms to Medicare's physician and hospital payment systems. Prescription drug spending growth accelerated throughout the time period; it grew fastest among the nonelderly, for whom prescription drug insurance coverage is most extensive.

Entities:  

Mesh:

Year:  2004        PMID: 15318578     DOI: 10.1377/hlthaff.23.4.176

Source DB:  PubMed          Journal:  Health Aff (Millwood)        ISSN: 0278-2715            Impact factor:   6.301


  30 in total

1.  Prevalence of comorbid conditions with aging among patients with diabetes and cardiovascular disease.

Authors:  James W Davis; Richard Chung; Deborah T Juarez
Journal:  Hawaii Med J       Date:  2011-10

2.  The cost of an additional disability-free life year for older Americans: 1992-2005.

Authors:  Liming Cai
Journal:  Health Serv Res       Date:  2012-06-07       Impact factor: 3.402

3.  Renal mass biopsy to guide treatment decisions for small incidental renal tumors: a cost-effectiveness analysis.

Authors:  Pari V Pandharipande; Debra A Gervais; Rebecca I Hartman; Mukesh G Harisinghani; Adam S Feldman; Peter R Mueller; G Scott Gazelle
Journal:  Radiology       Date:  2010-09       Impact factor: 11.105

4.  The boomers are coming: a total cost of care model of the impact of population aging on health care costs in the United States by Major Practice Category.

Authors:  E Mary Martini; Nancy Garrett; Tammie Lindquist; George J Isham
Journal:  Health Serv Res       Date:  2007-02       Impact factor: 3.402

Review 5.  Counting backward to health care's future: using time-to-death modeling to identify changes in end-of-life morbidity and the impact of aging on health care expenditures.

Authors:  Greg Payne; Audrey Laporte; Raisa Deber; Peter C Coyte
Journal:  Milbank Q       Date:  2007-06       Impact factor: 4.911

6.  Uncoupling lifespan and healthspan in Caenorhabditis elegans longevity mutants.

Authors:  Ankita Bansal; Lihua J Zhu; Kelvin Yen; Heidi A Tissenbaum
Journal:  Proc Natl Acad Sci U S A       Date:  2015-01-05       Impact factor: 11.205

Review 7.  The effect of population aging on health expenditure growth: a critical review.

Authors:  Claudine de Meijer; Bram Wouterse; Johan Polder; Marc Koopmanschap
Journal:  Eur J Ageing       Date:  2013-05-15

8.  How a Mutation that Slows Aging Can Also Disproportionately Extend End-of-Life Decrepitude.

Authors:  Katie Podshivalova; Rex A Kerr; Cynthia Kenyon
Journal:  Cell Rep       Date:  2017-04-18       Impact factor: 9.423

9.  Cost-effectiveness of tolvaptan in autosomal dominant polycystic kidney disease.

Authors:  Kevin F Erickson; Glenn M Chertow; Jeremy D Goldhaber-Fiebert
Journal:  Ann Intern Med       Date:  2013-09-17       Impact factor: 25.391

10.  Can broader diffusion of value-based insurance design increase benefits from US health care without increasing costs? Evidence from a computer simulation model.

Authors:  R Scott Braithwaite; Cynthia Omokaro; Amy C Justice; Kimberly Nucifora; Mark S Roberts
Journal:  PLoS Med       Date:  2010-02-16       Impact factor: 11.069

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.